The nucleotide analog 2′, 2′-difluoro 2′deoxycytidine, also known as dFdC or gemcitabine, is a potent inhibitor of the RNR complex, an essential complex in FA- and non-FA HNSCC. This evidence concerns the gene NR2E3 and head and neck squamous cell carcinoma.